Taxol and other microtubule-interactive agents

Current Opinion in Oncologic, Endocrine and Metabolic Investigational Drugs

Volumn 2, Issue 3, 2000, Pages 293-304

  Fojo, T ^a   Giannakakou, P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Drug resistance; Microtubule destabilizing agents; Microtubule stabilizing agents; Microtubules; Paclitaxel; Tubulin

Indexed keywords

ALPHA TUBULIN; BETA TUBULIN; COLCHICINE; CRYPTOPHYCIN DERIVATIVE; DISCODERMOLIDE; DOCETAXEL; ELEUTHEROBIN; EPOTHILONE A; EPOTHILONE B; GLYCOPROTEIN P; HEMIASTERLIN A; HEMIASTERLIN B; ISOLAULIMALIDE; LAULIMALIDE; MICROTUBULE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; NAVELBINE; NOCODAZOLE; PACLITAXEL; SARCODICTYIN; TRIPEPTIDE DERIVATIVE; TUBULIN; UNCLASSIFIED DRUG; VINBLASTINE SULFATE; VINCA ALKALOID; VINCRISTINE SULFATE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BINDING AFFINITY; DRUG BINDING SITE; DRUG EFFECT; DRUG INHIBITION; DRUG ISOLATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; MICROTUBULE; MICROTUBULE ASSEMBLY; MOUSE; NONHUMAN; PHOSPHORYLATION; REVIEW; SOLID TUMOR;

EID: 0033863814     PISSN: 14648466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. The use and action of drugs in analyzing mitosis
2. Mechanisms of action of and resistance to antitubulin agents: Microtubule dynamics, drug transport, and cell death
3. Microtubules and actin filaments: Dynamic targets for cancer chemotherapy
4. Microtubules and signal transduction
5. Tubulin dynamics in cultured mammalian cells
6. Microtublue dynamics in interphase cells
7. Microtubules are stabilized in confluent epithelial cells but not in fibroblasts
8. Real-time visualization of cell cycle-dependent changes in microtubule dynamics in cytoplasmic extracts
9. Mechanism of inhibition of cell proliferation by Vinca alkaloids
10. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations
11. Kinetic stabilization of microtubule dynamic instability in vitro by vinblastine
12. Differential effects of vinblastine on polymerization and dynamics at opposite microtubule ends
13. Vinblastine suppresses dynamics of individual microtubules in living interphase cells
14. Interaction of vinblastine ith steady-state microtubules in vitro
15. Identification of a distinct class of vinblastine binding sites on microtubules
16. Binding of vinblastine to stabilized microtubules
17. Characterization of microtubule assembly in porcine brain extracts by viscometry
18. Addition of colchicine-tubulin complex to microtubule ends: The mechanisms of substoichiometric colchicine poisoning
19. Mechanism of colchicine-dimer addition to microtubule ends: Implications for the microtubule polymerization mechanism
20. Mechanism of action cryptophycin. Interaction with the Vinca alkaloid of tubulin
21. Characterization of the interaction of cryptophycin 1 with tubulin: Binding in the Vinca domain, competitive inhibition of dolastatin 10 binding, and an unusual aggregation reaction
22. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1
23. Cytotoxic peptides hemiasterlin, hemiasterlin A and hemiasterlin B induce mitotic arrest and abnormal spindle formation
24. Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: Comparison with dolastatin 10 and cryptophycin 1.
25. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia
26. Promotion of microtubule assembly in vitro by taxol
27. Taxol stabilizes mictotubules in mouse fibroblast cells
28. How taxol modulates microtubule disassembly
29. Taxol binds to polymerized tubulin in vitro
30. Assembly of purified GDP-tubulin into mictotubules induced by taxol and taxotere: Reversibility, ligand stoichmetry, and competition
31. 3'-(p-Azidobenzamido)taxol photelabels the N-terminal 31 amino acids of β-tubulin
32. Characterization of the taxol binding site on the microtubule. 2-(m-Azidobenzoyl)taxol photolabels a peptide (amino acids 217-231) of beta-tubulin
33. Taxol-induced polymerization of purified tubulin. Mechanism of action
34. Taxol assembles tubulin in the absence of exogenous guanosine 5'-triphosphate or microtubule-associated protein
35. Linkages between the effects of taxol, colchicine, and GTP on tubulin pololymerization
36. Substoichoimetric binding of taxol suppresses microtubule dynamics
37. Low potency of taxol at microtubule minus ends: Implications for its antimitotic and therapuetic mechanism
38. Molecular effects of paclitaxel: Myths and reality (a critical review)
39. Microtubule-interfering agents activate c-Jun N-termianl kinase/stress-activated protein kinase through both Ras and apoptosis sinal-regulating kinase pathways
40. Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK)
41. Taxol induces tyrosine phosphorylation of Shc and its association with Grb2 in murine RAW 264.7 cells
42. Raf-1/bcl-2 phosphorylation: A step from microtubule damage to cell death
43. Taxol induction of p21WAF1 and p53 requires c-raf-1
44. Mechanisms of Taxol-induced cell death are concentration dependent
45. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells
46. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway
47. Bcl-xl is phosphorylated in malignant cells following microtubule disruption
48. Microtubule-damaging drugs triggered bcl2 phosphorylation - Requirement of phosphorylation on both serine-70 and serine-87 residues of bcl2 protein
49. Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells
50. Inactivation of Bcl-2 by phosphorylation
51. 'Loop' domain in necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis
52. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells
53. Shared actions of endotoxin and taxol on TNF receptors and TNF release
54. Epothilone B stabilizes microtubuli of macrophages like taxol without showing taxol-like endotoxin activity
55. Taxane-mediated gene induction is independent of microtubule stabilization: Induction of transcription regulators and enzymes that modulate inflammation and apoptosis
56. Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations
57. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action
58. Discodermolide, a cytotoxic marine agent that stabilized microtubules more potently than taxol
59. Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R))
60. Elurtherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol)
61. Solid and solution phase synthesis and biological evaluation of combinatorial sarcodictyin libraries
62. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents
63. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells
64. The coral-derived natural products eleutherobin and sarcodictyins A and B: Effects on the assembly of purified tubulin with and without microtubule-associated protein and binding at the polymer taxoid site
65. Chemical biology of epothilones
66. Epothilone A and B - Novel 16-membered macrolides with cytotoxic activity: Isolation, crystal structure, and conformation in solution
67. Structure-activity relationships of the epothilones and the first in vivo comparison with paclitaxel
68. Total synthesis of (-)-epothilone B: An extension of the Suzuki coupling method and insights into structure-activity relationships of the epothilones
69. Desoxyepothilone B: An efficacious microtubule-targeted antitumor agent with a promising in vivo profile relative to epothilone B.
70. Desoxyepthilone B is curative against human tumor xenografts that are refractory to paclitaxel
71. Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization
72. Synthesis of epothilones A and B in solid and solution phase
73. High-resolution model of the microtubule-structure of the alpha beta tubulin dimer by electron crystallography
74. Structure of the alpha beta tubulin dimer by electron crystallography
75. A common pharmacophore for epothilone and taxanes: Molecular basis for drug resistance conferred by tubulin mutations in human cancer cells
76. The biosynthetic gene cluster for the microtubule-stabilizing agents epothilones A and B from Sorangium cellulosum So ce90. Cloning and heterologous expression of the epothilone gene cluster
77. Cloning and heterologous expression of the epothilone gene cluster
78. Discodermolide - A new bioactive polyhydroxylated lactone from the marine sponge Discodermia-Dissoluta
79. Discodermolide - A new, marine-derived immunosuppressive compound. 1. In vitro studies
80. Discodermolide - A new, marine-derived immunosuppressive compound. 1. In vitro studies
81. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines
82. Discodermolide: Just another microtubule-stabilizing agent? No! A lesson in synergy
83. Sarcodictyin A and two novel diterpenoid glycosides, eleuthosides A and B, from the soft coral Eleutherobia aurea
84. Isolation from the mediterranean stoloniferan coral sarcodictyon-roseum of sarcodictyin c, d, e, and f, novel diterpenoidic alcohols esterified by (e)- or (z)-n(1)-methylurocanic acid - Failure of the carbon-skeleton type as a classification criterion
85. Eleutherobin, a new cytotoxin that mimics paclitaxel (Taxol) by stabilizing microtubules
86. Laulimalides - New potent cyto-toxic macrolides from a marine sponge and a nudibranch predator
87. Fijianolides, polyketide heterocycles from a marine sponge
88. P-glycoprotein and resistance to anticancer drugs
89. Multidrug (pleitropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA
90. Expression of a full-length cDNA for the human 'MDR1' gene confers resistance to colchicine, doxorubicin, and vinblastine
91. Resistance to paclitaxel mediated by P-glycoprotein can be modulated by changes in the schedule of administration
92. Taxol: Mechanisms of action and resistance
93. Normal p53 status and function despite the development of drug resistance in human breast cancer cells
94. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells
95. Double knockout of the MRP gene leads to increased drug sensitivity in vitro
96. Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein
97. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes
98. Novel mechanism of resistance to paclitaxel (Taxol) in human K562 leukemia cells by combined selection with PSC 833
99. Altered expression of M beta 2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance
100. Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance
101. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes
102. Increased microtubule assembly in bovine brain tubulin lacking the type III isotype of beta-tubulin
103. Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin
104. A beta-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance
105. Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: Analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype
106. TRAG-3, a novel gene, isolated from a taxol-resistant ovarian carcinoma cell line